Merck in Negotiations to Acquire Revolution Medicines for Up to $32 Billion

TL;DR
Merck is in negotiations to acquire biotech firm Revolution Medicines, with the deal not yet finalized and other bidders potentially involved, causing Revolution's shares to rise.
- Merck in talks to buy biotech Revolution Medicines, FT reports Yahoo Finance
- Revolution Medicines takeout speculation spotlight shines on Merck & Co. FirstWord
- Merck in Talks to Buy Revolution Medicines Per Financial Times Report Yahoo Finance
- Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn Financial Times
- AbbVie denies media reports of talks to buy Revolution Medicines Reuters
Want the full story? Read the original reporting
Read on Yahoo Finance